Science

IIT-Hyderabad develops AI-based Covid-19 test kit priced at ₹600

Our Burea Hyderabad | Updated on June 07, 2020 Published on June 07, 2020

A view of Indian Institute of Technology-Hyderabad campus

One of the biggest hurdles in treating Covid-19 patients is the cost of the screening test, which can go up to ₹4,500-6,000 depending on the availability of the test kits.

A researcher at the Indian Institute of Technology (IIT-Hyderabad) has come out with a test kit that would cost only ₹600 per test. An IIT-H spokesperson said the cost will come down further to ₹350 when volumes go up.

Powered by Artificial Intelligence (AI), the test kit would give the results in 20 minutes, breaking another barrier in the treatment of the viral infection. “The test kit has already been field tested at ESIC Medical College and Hospital in Hyderabad to ascertain its efficiency,” an IIT-H spokesperson said.

“It can be transported quickly, enabling the test to be conducted at the point-of-care. A major benefit of this testing kit is that it does not require RT-PCR (Reverse Transcription Polymerase Chain Reaction),” he said.

The testing kit was developed by a team led by Shiv Govind Singh of the Department of Electrical Engineering at IIT-H. Suryasnata Tripathy, a postdoctoral fellow, and Patta Supraja, a fourth-year doctoral student, were among Shiv Govind Singh’s research team.

“Once the testing kit is mass-produced, it will enable us to scale-up testing for Covid-19 suspects in a widespread manner,” BS Murty, Director, IIT Hyderabad, said.

The unique feature of the testing kit includes identifying the unique sequence of conserved region of Covid-19 genome and detecting it. The team also developed AI tools to capture extensive data points to minimise the errors in decision making.

The team has sought approval of the Indian Council of Medical Research (ICMR) for mass production of the test kit.

Published on June 07, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
ARCI develops magnetocaloric material for cancer treatment